Raleigh Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37
| Closed | -$26.4K | – | 932 |
|
|
2024
Q4 | $26.4K | Sell |
37
-10
| -21% | -$7.12K | 0.01% | 409 |
|
|
2024
Q3 | $49.4K | Buy |
47
+2
| +4% | +$2.1K | 0.02% | 318 |
|
|
2024
Q2 | $47.3K | Buy |
45
+7
| +18% | +$7.36K | 0.02% | 305 |
|
|
2024
Q1 | $36.6K | Buy |
38
+19
| +100% | +$18.3K | 0.02% | 340 |
|
|
2023
Q4 | $16.7K | Buy |
19
+11
| +138% | +$9.66K | 0.01% | 477 |
|
|
2023
Q3 | $6.58K | Hold |
8
| – | – | ﹤0.01% | 633 |
|
|
2023
Q2 | $5.75K | Hold |
8
| – | – | ﹤0.01% | 615 |
|
|
2023
Q1 | $6.57K | Buy |
+8
| New | +$6.57K | ﹤0.01% | 578 |
|
|
2022
Q1 | – | Sell |
-6
| Closed | -$4K | – | 666 |
|
|
2021
Q4 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 251 |
|